KRISTY KIERMAIER: Open Payments
NPI 1073227740 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 8 payments from 4 companies in 2025. Trend: 2023 $306 · 2024 $1,083 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $438 |
| Gilead Sciences, Inc. | 1 | $75 |
| Mallinckrodt Hospital Products Inc. | 1 | $58 |
| Madrigal Pharmaceuticals | 1 | $54 |
Products named: XIFAXAN, TERLIVAZ, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
